Phase I/II study of the pharmacokinetics, safety and efficacy of S-1 in patients with advanced hepatocellular carcinoma.
Furuse
Junji
J
Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital East, Kashiwa, Japan. jfuruse@ks.kyorin-u.ac.jp
Okusaka
Takuji
T
Kaneko
Shuichi
S
Kudo
Masatoshi
M
Nakachi
Kohei
K
Ueno
Hideki
H
Yamashita
Tatsuya
T
Ueshima
Kazuomi
K